The approved product is bioequivalent to the reference listed drug
product (RLD), Tylenol tablets, extended release.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-india-gets-usfda-nod-for-pain-relief-drug/articleshow/68938684.cms
Thursday, April 18, 2019
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment